Methods, compositions, and devices for supplying dietary fatty acid needs
Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.
1. A medical device for hydrolyzing a nutritional composition for ingestion by a subject, the device comprising:
one or more external walls forming an outer boundary of the device, the one or more external walls forming an enclosure, wherein the one or more external walls are formed of a semi-permeable material; and
an immobilized lipase contained within the enclosure,
wherein the immobilized lipase is configured to hydrolyze fatty acid triglycerides;
wherein the semi-permeable material surrounds the immobilized lipase such that the immobilized lipase is contained inside the enclosure and the nutritional composition is able to flow through the semi-permeable material.
2. The medical device of claim 1 , wherein the enclosure includes a teabag-like structure.
3. The medical device of claim 1 wherein the enclosure includes a pocket.
4. The medical device of claim 1 , wherein the immobilized lipase is immobilized to an inner surface of at least one of the one or more external walls.
5. The medical device of claim 1 , wherein the immobilized lipase is immobilized to a structure contained within the enclosure.
6. The medical device of claim 5 , wherein the structure comprises at least one of particles, balls, or beads.
7. The medical device of claim 1 , wherein the immobilized lipase is immobilized by one or more of adsorption, ionic binding, covalent binding, cross-linking, encapsulation, or entrapment.
8. The medical device of claim 1 , wherein the immobilized lipase is chosen from Chromobacterium viscosum, Pseudomonas fluorescens, Burcholderia cepacia , or Rhizopus oryzae.
9. The medical device of claim 1 , comprising a plurality of enclosures.
10. The medical device of claim 1 , further comprising a rod-shaped extension having a distal end and a proximal end, wherein the enclosure is coupled to a distal region of the rod-shaped extension.
11. The medical device of claim 1 , wherein the one or more external walls form a plurality of pockets.
12. The medical device of claim 1 , wherein the semi-permeable material is a mesh or a screen.
13. A medical device for hydrolyzing a nutritional composition for ingestion by a subject, the device comprising:
a rod-shaped extension having a proximal end and a distal end;
one or more walls forming one or more pockets at a distal region of the rod-shaped extension, wherein the one or more walls are formed of a semi-permeable material; and
a lipase immobilized within the one or more pockets,
wherein the semi-permeable material surrounds the lipase such that the lipase is contained inside the one or more pockets and the nutritional composition is able to flow through the semi-permeable material.
14. The medical device of claim 13 , wherein the immobilized lipase is immobilized to a structure within the one or more pockets.
15. The medical device of claim 14 , wherein the structure comprises at least one of particles, balls, or beads.
16. The medical device of claim 13 , wherein a plurality of pockets are coupled to the distal region of the rod-shaped extension.
17. The medical device of claim 13 , wherein the immobilized lipase is configured to hydrolyze fatty acid triglycerides.
18. The medical device of claim 13 , wherein the immobilized lipase is immobilized by one or more of adsorption, ionic binding, covalent binding, cross-linking, encapsulation, or entrapment.
19. The medical device of claim 13 , wherein the immobilized lipase is chosen from Chromobacterium viscosum, Pseudomonas fluorescens, Burcholderia cepacia , or Rhizopus oryzae.
20. The medical device of claim 13 , wherein the semi-permeable material is a mesh or a screen.
21. A medical device for hydrolyzing a nutritional composition for ingestion by a subject, the device comprising:
one or more external walls forming an outer boundary of the device, the one or more external walls forming a teabag-like structure, wherein the one or more external walls are formed of a semi-permeable material; and
a lipase immobilized to a structure contained within the teabag-like structure,
wherein the semi-permeable material surrounds the lipase, while allowing passage of the nutritional composition into and out of the teabag-like structure, and wherein the immobilized lipase is configured to hydrolyze fatty acid triglycerides.
22. The medical device of claim 21 , wherein the immobilized lipase is immobilized by one or more of adsorption, ionic binding, covalent binding, cross-linking, encapsulation, or entrapment.
23. The medical device of claim 21 , wherein the immobilized lipase is chosen from Chromobacterium viscosum, Pseudomonas fluorescens, Burcholderia cepacia , or Rhizopus oryzae.
24. The medical device of claim 21 , wherein the semi-permeable material is a mesh or a screen.
25. A medical device for hydrolyzing a nutritional composition for ingestion by a subject, the device comprising:
one or more external walls forming an outer boundary of the device, the one or more external walls forming a teabag-like structure, wherein the one or more external walls are formed of a semi-permeable material; and
an immobilized lipase contained within the teabag-like structure, wherein the immobilized lipase is configured to hydrolyze fatty acid triglycerides;
wherein the semi-permeable material surrounds the immobilized lipase such that the immobilized lipase is contained inside the teabag-like structure and the nutritional composition is able to flow through the semi-permeable material.
26. The medical device of claim 25 , wherein the immobilized lipase is immobilized to a structure within the teabag-like structure.
27. The medical device of claim 26 , wherein the structure comprises at least one of particles, balls, or beads.
28. The medical device of claim 25 , wherein the immobilized lipase is chosen from Chromobacterium viscosum, Pseudomonas fluorescens, Burcholderia cepacia , or Rhizopus oryzae.
29. The medical device of claim 25 , wherein the immobilized lipase is immobilized by one or more of adsorption, ionic binding, covalent binding, cross-linking, encapsulation, or entrapment.